Polio vaccine new sequential schedule to be discussed by ACIP at Feb. 21-22 meeting.

POLIO VACCINE SEQUENTIAL SCHEDULES WILL BE DISCUSSED BY ACIP FEB. 21-22 at a meeting of the Advisory Committee on Immunization Practices: a draft recommendation is now being written. The sequential dosing schedule being considered by ACIP is two inactivated doses administered subcutaneously at two and four months followed by two oral doses at six to 12 months and 12 to 18 months. Connaught's Ipol is the only approved IPV in the U.S.